Sanofi-Aventis sues Novopharm for patent infringement in Canada
Advertisement
Sanofi-aventis has learned through the Canadian Ministry of Health website that Novopharm Limited has obtained marketing approval in Canada for a product claiming to be generic enoxaparin.
Sanofi-aventis companies Aventis Pharma Inc. and Aventis Pharma S.A. are bringing suit in the Federal Court against Novopharm for patent infringement of Canadian patent 2045433, which covers Lovenox®.
Sanofi-aventis will vigorously defend its legal rights with respect to this patent.